Finished
RPE-P/TLIF for Lumbar Spinal Stenosis With Instability
NCT06290908 · Wen-xi Sun · Updated 4 March 2024
- What is being tested
- RPE-P/TLIF
- For
- Spinal Stenosis
- Kind of study
- Watches patients without assigning a treatment. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 80 years. About 26 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 4 Sept 2018, ends 1 Feb 2024. Registered 4 March 2024.
- Results
- None posted yet.
In the researchers' words
Objective To analyze the effectiveness and safety of robot-assisted percutaneous endoscopic posterior/transforaminal lumbar interbody fusion (RPE-P/TLIF) in the treatment of lumbar spinal stenosis with instability. Methods A single-center prospective study from September 2018 to April 2022, patients with lumbar spinal stenosis and instability who met the inclusion and exclusion criteria were treated with RPE-P/TLIF. Pain visual analog scale (VAS) was used to evaluate the degree of low back pain and lower limb pain before operation, 1 month, 6 months, 1 year after operation and at the final follow-up, and the Oswestry disability index (ODI) was used to evaluate the degree of lumbar spinal function. At the last follow-up, MacNab criteria were used to evaluate the clinical efficacy. Imaging evaluation included the measurement of intervertebral space height, lumbar physiological curvature, fusion rate and pedicle screw accuracy by preoperative and lateral X-ray films.
Sites
- Guangdong Provincial Hospital of Traditional Chinese MedicineGuangzhou, China
